Exhaled nitric oxide predicts persistence of wheezing, exacerbations, and decline in lung function in wheezy infants

M Elliott1, S L Heltshe, D C Stamey

  • 1Division of Pulmonary Medicine, Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, WA, USA.

Insights

Single-breath fraction of exhaled nitric oxide (SB-FENO) effectively predicts persistent wheezing in young children. This method outperformed other tests in forecasting exacerbations and wheezing duration.

Area of Science:

  • Pediatric Pulmonology
  • Respiratory Medicine
  • Biomarkers in Asthma

Background:

  • Limited data exists on predicting wheezing persistence, exacerbations, and lung function decline in infants with recurrent wheezing.
  • Fraction of exhaled nitric oxide (FENO) is a potential non-invasive biomarker.

Purpose of the Study:

  • To compare the predictive values of single-breath FENO (SB-FENO), tidal-breathing FENO (tidal-FENO), bronchodilator responsiveness (BDR), and the Asthma Predictive Index (API) for clinical outcomes in infants with recurrent wheezing.
  • To assess these markers' ability to predict wheezing persistence, exacerbations, and lung function changes up to age 3 years.

Main Methods:

  • A longitudinal cohort study enrolled 44 infants and toddlers with recurrent wheezing.
  • Infant pulmonary function tests (iPFTs), SB-FENO, and tidal-FENO were measured at enrollment.
  • Clinical outcomes and follow-up iPFTs were assessed at age 3 years.

Main Results:

  • An enrollment SB-FENO level ≥ 30 p.p.b. predicted wheezing persistence at age 3 years with high accuracy (AUC 0.86).
  • SB-FENO demonstrated superior sensitivity and specificity compared to tidal-FENO, BDR, and API for predicting wheezing persistence and exacerbations.
  • Both SB-FENO and tidal-FENO were associated with a decline in lung function (FEV0.5 and FEF25-75) by age 3 years.

Conclusions:

  • SB-FENO is a more effective predictor of future exacerbations and persistent wheezing in infants and toddlers than tidal-FENO, BDR, or API.
  • Elevated SB-FENO and tidal-FENO levels at enrollment may indicate a risk of long-term lung function decline.
Abstract

Related Concept Videos

Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
73
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
311
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
5.5K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.6K
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
77
Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
50.7K